Relationships Among Morphine Metabolism, Pain and Side Effects During Long-Term Treatment: An Update

作者: Gertrud Andersen , Lona Christrup , Per Sjøgren

DOI: 10.1016/S0885-3924(02)00531-6

关键词:

摘要: The two metabolites of morphine, morphine-3-glucuronide (M3G) and morphine-6-glucuronide (M6G), have been studied intensively in animals humans during the past 30 years order to elucidate their precise action possible contribution desired effects side seen after morphine administration. M3G M6G are formed by glucuronidation, mainly liver, excreted kidneys. found cerebrospinal fluid single as well multiple doses morphine. binds opioid receptors, animal studies demonstrated that may be a more potent analgesic than Results from human regarding effect not unanimous. potency ratio between systemic has settled, but is probably lower previously assumed. Hitherto, only few evidence for contributory overall observed Several administration accompanied fewer milder degree opioid-like administration, most used displays very low affinity receptors no activity. Animal shown antagonize M6G, this. also connected certain neurotoxic symptoms, such hyperalgesia, allodynia myoclonus, which or high animals. symptoms reported sporadically treated primarily with role eliciting fully elucidated.

参考文章(134)
Lona L Christrup, Per Sjøgren, Niels-Henrik Jensen, Anne-Marie Banning, Karsten Elbæk, Annette K Ersbøll, Steady-state kinetics and dynamics of morphine in cancer patients: is sedation related to the absorption rate of morphine? Journal of Pain and Symptom Management. ,vol. 18, pp. 164- 173 ,(1999) , 10.1016/S0885-3924(99)00068-8
T Reisine, Opioid analgesics and antagonists Goodman & Gilman's The pharmacological basis of therapeutics. ,(1996)
Takashi TAN, Masashi KURAMOTO, Terutaka TAKAHASHI, Hideo NAKAMURA, Yutaka NAKANISHI, Yu IMASATO, Hidetoshi YOSHIMURA, Characteristics of the gastrointestinal absorption of morphine in rats. Chemical & Pharmaceutical Bulletin. ,vol. 37, pp. 168- 173 ,(1989) , 10.1248/CPB.37.168
Michael W.H. Coughtrie, Birgitta Ask, Anders Rane, Brian Burchell, Robert Hume, The enantioselective glucuronidation of morphine in rats and humans: Evidence for the involvement of more than one UDP-glucuronosyltransferase isoenzyme Biochemical Pharmacology. ,vol. 38, pp. 3273- 3280 ,(1989) , 10.1016/0006-2952(89)90625-4
R. Callaghan, J.R. Riordan, Synthetic and natural opiates interact with P-glycoprotein in multidrug-resistant cells. Journal of Biological Chemistry. ,vol. 268, pp. 16059- 16064 ,(1993) , 10.1016/S0021-9258(18)82357-2
M L Slevin, J A Wedzicha, S P Joel, M Maclean, P I Thompson, L John, Respiratory depression following morphine and morphine-6-glucuronide in normal subjects. British Journal of Clinical Pharmacology. ,vol. 40, pp. 145- 152 ,(1995)
Rashmi V. Patwardhan, Raymond F. Johnson, Anastacio Hoyumpa, John J. Sheehan, Paul V. Desmond, Grant R. Wilkinson, Robert A. Branch, Steven Schenker, Normal Metabolism of Morphine in a Cirrhosis Gastroenterology. ,vol. 81, pp. 1006- 1011 ,(1981) , 10.1016/S0016-5085(81)80005-4
Ulrich Bickel, William M. Pardridge, Dafang Wu, Young-Sook Kang, Blood-brain barrier permeability to morphine-6-glucuronide is markedly reduced compared with morphine. Drug Metabolism and Disposition. ,vol. 25, pp. 768- 771 ,(1997)
B Monsarrat, J M Zajac, B Frances, R Gout, J Cros, Further evidence that morphine-6 beta-glucuronide is a more potent opioid agonist than morphine. Journal of Pharmacology and Experimental Therapeutics. ,vol. 262, pp. 25- 31 ,(1992)